Croissy-Beaubourg, September 24, 2020, 8:00am CEST – THERADIAG (ISIN: FR0004197747, Ticker: ALTER, eligible for the French PEA-PME personal equity plan), a company specializing in in vitro diagnostics and theranostics, has opened a new site in…
Croissy-Beaubourg, September 23, 2020, 5:45pm CEST – THERADIAG (ISIN: FR0004197747, Ticker: ALTER), a company specializing in in vitro diagnostics and theranostics, today announces that its half-year financial report as at 30 June 2020 has been…
Croissy-Beaubourg (77), September 21, 2020, 5:45 pm CEST - Theradiag, a French company specializing in diagnostic tests for autoimmune and infectious diseases, today announces the market launch of a CE-marked antigen test for detecting COVID-19.On…